NICE Recommends Abaloparatide for Osteoporosis ...

By HEOR Staff Writer

September 10, 2024

Introduction The National Institute for Health and Care Excellence (NICE) has recently recommended abaloparatide for treating osteoporosis in postmenopausal women, trans me...
A Comparative Study on PRO Symptom Monitoring Approaches
Enhancing Patient Care in Oncology through Remote Patient Monitoring
Disparities in HPV Vaccination by Health Care Facility Type
HPV Vaccination Coverage in Japan: Challenges and Future Directions
The Power of Paediatric Biobanks: Advancing Child Health Research
Pharmacoeconomic Comparison of Anaprazole and Ilaprazole for Duodenal Ulcer T...
Clinical Trial Screening with GPT-4: The RECTIFIER Framework
A New Approach to Cardiovascular Risk Assessment for Statin Therapy
The Shift to Value-Based Drug Pricing in the United States
Cost Savings on Generic Drugs: Transparent Pricing Models
Self-Management of Vaginal Pessaries: A Viable Alternative for Pelvic Organ P...
Treatment Effect Estimation with AI: The CURE Framework